Measles immunity monitoring after bone marrow transplant
Treatments studied
Part of Genetic & congenital, Infections clinical trials.
This study checks how well adults stay protected against measles after they receive a donor bone marrow transplant. It helps doctors understand measles immune status and may guide future protection for transplant recipients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 75
- If you had a donor (allogeneic) bone marrow transplant, it must be at least 24 months ago
- Your original blood cancer/condition should be in complete remission, and transplant engraftment should have worked
- You should not have extensive chronic graft-versus-host disease (ongoing immune side effects from the transplant)
- Avoid certain immune-suppressing medicines within the past 3 months (or longer for some drugs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks how certain blood “biomarkers” change after you receive donor stem cells to rebuild your blood and immune system. The goal is to learn whether these markers can better predict your immune recovery after transplant.
This trial checks if measuring a specific virus marker in your blood after a stem cell transplant can help predict or prevent transplant complications. You would have extra blood tests to guide your care.
This trial tests whether removing certain immune cells (T cells) from the donor transplant can lower the risk of chronic graft-versus-host disease (long-term immune attack after transplant) in children and young adults with blood cancers. If you qualify, it may help improve transplant outcomes while tracking safety and side effects.
This trial studies how well a donor bone marrow (stem cell) transplant works for people with inherited immune system problems (called immune deficiencies). It’s for patients who haven’t improved with usual treatment or don’t have another good option.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
This study collects medical information from people with certain non-cancer conditions who receive a stem cell transplant. It may help doctors better understand transplant outcomes and care, since the study focuses on data collection rather than adding new treatment.
Hear when a new Transplantation, Hematopoietic Stem Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.